For new neuro drugs, faster isn't always better : vimarsana.

Drugmakers are required to conduct confirmatory trials to prove accelerated approval therapies work, but those can take years to complete.

Related Keywords

Cherie Duvall Jones , Paul Melmeyer , Katherine Ellen Foley , Kelly Hooper , Lawrence Tabak , Merck Covid , Peter Maybarduk , Jared Hopkins , David Lim , Caleb Alexander , Giovanna Faggionato , Sabin Vaccine Institute , Johns Hopkins Bloomberg School Of Public Health , European Commission , Research Corner , Pfizer , B Health , Muscular Dystrophy Association , World Health Organization , Institute For Clinical , Johns Hopkins Bloomberg School , Muscular Dystrophy , Lauren Gardner , Economic Review , Public Citizen , Prescription Pulse , Director Lawrence Tabak , Wall Street Journal ,